ABSTRACT Background Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity
of randomized studies, this expert consensus document represents an initiative by the …

Lung cancer is the leading cause of cancer-related death in the United States, with an
average five-year survival rate of 15 percent. Smoking remains the predominant risk factor …

To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The Second …

Bronchopulmonary neuroendocrine tumors (BP‐NETs) comprise≈ 20% of all lung cancers
and represent a spectrum of tumors arising from neuroendocrine cells of the BP‐epithelium …

Lung cancer's enduring global significance necessitates ongoing advancements in
diagnostics and therapeutics. Recent spotlight on proteomic and genetic biomarker research …

Guided bronchoscopy offers a minimally invasive and safe method for accessing
indeterminate pulmonary nodules. However, all current guided bronchoscopy systems rely …

Study objectives To characterize the feasibility, accuracy, and safety of the superDimension/
Bronchus system (SDBS)[superDimension, Ltd; Hertzliya, Israel] in navigating to previously …

Neuroendocrine tumors (NETs) of the lung comprise a heterogeneous population of tumors
ranging from welldifferentiated bronchial NETs to highly malignant and poorly differentiated …

Introduction The emergence of treatments for non-small cell lung carcinoma (NSCLC) with
differential efficacy and toxicity between subtypes has highlighted the importance of specific …

Study objectives: The aim of our study was to compare the diagnostic yield of two
bronchoscopic procedures: endobronchial ultrasound-driven transbronchial biopsy (EBUS …